Agenda
Due to the ongoing spread of COVID-19, the Alliance for Regenerative Medicine (ARM) is unable to produce the 2020 conference. We would like to thank all of the panelists and company presenters below who were slated to participate.
7:45am – 8:45am | REGISTRATION
8:45am | GENERAL SESSION AND PARTNERING OPENS
WELCOME AND STATE OF THE INDUSTRY REMARKS {Gaudi 3}
Speaker:
Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine (ARM)
KEYNOTE ADDRESS & FIRESIDE CHAT {Gaudi 3}
Speaker:
Guido Rasi, M.D., Director General, European Medicines Agency (EMA)
Fireside Chat With:
Miguel Forte, M.D., Ph.D., CEO, Bone Therapeutics
PLENARY SESSION: LESSONS LEARNED FROM COMMERCIAL PIONEERS {Gaudi 3}
Chair:
Sven Kili, M.D., Founder, Sven Kili Consulting
Speakers:
Lisa Deschamps, SVP and Chief Business Officer, AveXis
Alison Finger, Chief Commercial Officer, bluebird bio
Robin Kenselaar, SVP and General Manager EMEA, Orchard Therapeutics
10:45am – 11:15am | MORNING BREAK
11:15am – 12:30pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 3}
COMPANY PRESENTATIONS {Gaudi 2}
12:30pm – 1:45pm | LUNCH
Sponsored by Covance
1:45pm – 3:30pm | CONCURRENT TRACKS
PANEL: HOSPITAL EXEMPTION: IMPLICATIONS FOR PATIENTS AND INNOVATION {Gaudi 3}
1:45pm – 2:45pm
COMPANY PRESENTATIONS {Gaudi 2}
COMPANY PRESENTATIONS {Gaudi 3}
COMPANY PRESENTATIONS {Gaudi 2}
3:30pm – 4:00pm | AFTERNOON BREAK
4:00pm – 5:00pm | CONCURRENT TRACKS
PANEL: CELL AND GENE THERAPIES FOR CHRONIC CONDITIONS {Gaudi 3}
4:00pm – 5:00pm
COMPANY PRESENTATIONS {Gaudi 2}
5:00pm | PARTNERING CLOSES
6:00pm – 9:00pm | NETWORKING BASH
Sponsored by Avectas
7:30am – 8:30am | REGISTRATION
8:30am | GENERAL SESSION AND PARTNERING OPENS
WELCOME REMARKS {Gaudi 3}
Speaker:
Matthew Patterson, Strategic Advisor, Audentes Therapeutics, An Astellas Company; Chairman, Alliance for Regenerative Medicine (ARM)
8:45am – 10:45am | CONCURRENT TRACKS
PANEL: THE NEXT WAVE OF COMMERCIAL DEVELOPMENT {Gaudi 3}
8:45am – 9:45am
COMPANY PRESENTATIONS {Gaudi 2}
SPOTLIGHT SESSION: PATIENT-FOCUSED TOPIC {Gaudi 3}
9:45am – 10:15am
COMPANY PRESENTATIONS {Gaudi 2}
FIRESIDE CHAT: DISCUSSION WITH GERMAN MARKET ACCESS POLICYMAKER {Gaudi 3}
10:15am – 10:45am
COMPANY PRESENTATIONS {Gaudi 2}
10:45am – 11:15am | MORNING BREAK
11:15am – 12:30pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 3}
COMPANY PRESENTATIONS {Gaudi 2}
12:30pm – 1:45pm | LUNCH
Sponsored by Polyplus-Transfection
1:45pm – 3:00pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 2}
PANEL: DISRUPTIVE TECHNOLOGIES THAT WILL CHANGE THE CELL THERAPY LANDSCAPE {Gaudi 3}
2:15pm – 3:00pm
COMPANY PRESENTATIONS {Gaudi 2}
3:00pm – 3:30pm | AFTERNOON BREAK
3:30pm – 5:00pm | CONCURRENT TRACKS
COMPANY PRESENTATIONS {Gaudi 2}
PANEL: THE STATE OF MONEY {Gaudi 3}
Chair:
Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult
Speakers:
Christian Itin, Ph.D., Chairman and CEO, Autolus
Dmitry Kuzmin, Ph.D., Managing Partner, 4BIO Capital
Nicholas Moore, Managing Director, Healthcare Investment Banking, Stifel Financial
Ping Shek, Managing Director, Torreya
5:00pm | PARTNERING CLOSES
6:00pm – 8:00pm | WINE TASTING AND RECEPTION
Sponsored by Dark Horse Consulting
8:00am – 11:00am | ARM EU COMMITTEE MEETINGS
Open to ARM Members Only
